Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cost Effectiveness and Resource Allocation
Published in: Cost Effectiveness and Resource Allocation 1/2011

Open Access 01-12-2011 | Commentary

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions

Authors: Sitaporn Youngkong, Noor Tromp, Dereck Chitama

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2011

Login to get access

Excerpt

This commentary responds to the article by Goetghebeur et al [1], which applies the EVIDEM (Evidence and Value: Impact on DEcision-Making) framework to evaluate growth hormone therapy for Turner syndrome patients. The EVIDEM framework is developed to assist decision-makers in healthcare decisions, and encompasses a multi-criteria decision analysis (MCDA) matrix consisting of 15 quantifiable, and six qualitative components of decision. With this comprehensive set of criteria, relevant experts can assess the performance of health interventions, and results are input for informed and transparent healthcare decisions. …
Literature
1.
Goetghebeur M, Wagner M, Khoury H, Rindress D, Grégoire JP, Deal C: Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients. Cost Effectiveness and Resource Allocation 2010, 8: 4. 10.1186/1478-7547-8-4PubMedCentralPubMedCrossRef
2.
Goetghebeur M, Wagner M, Khoury H, Levitt R, Erickson L, Rindress D: Evidence and value: Impact on DEcisionMaking - the EVIDEM framework and potential applications. BMC Health Services Research 2008, 8: 270. 10.1186/1472-6963-8-270PubMedCentralPubMedCrossRef
3.
Baltussen R, Asbroek AHAt, Koolman X, Shrestha N, Bhattarai P, Niessen L: Priority setting using multiple criteria: should a lung health programme be implemented in Nepal? Health Policy and Planning 2007, 22: 178–185. 10.1093/heapol/czm010PubMedCrossRef
4.
Vargas V, Poblete S: Health prioritization: The case of Chile. Health Affairs 2008, 27: 782–792. 10.1377/hlthaff.27.3.782PubMedCrossRef
5.
Jehu-Appiah C, Baltussen R, Acquah C, Aikins M, Amah d'Almeida S, Bosu W, Koolman X, Lauer J, Osei D, Adjei S: Balancing equity and efficiency in health priorities in Ghana: The use of multicriteria decision analysis. Value in Health 2008, 11: 1081–1087. 10.1111/j.1524-4733.2008.00392.xPubMedCrossRef
6.
The International Health Policy Program, Health Intervention and Technology Assessment Program: Research for development of health benefit package under universal health care coverage scheme: Issue 1. Nonthaburi 2011.
7.
Daniels N: Accountability for reasonableness: Establishing a fair process for priority setting is easier than agreeing on principles. BMJ 2000, 321: 1300–1301. 10.1136/bmj.321.7272.1300PubMedCentralPubMedCrossRef
8.
Daniels N: Just health: Meeting health needs fairly. New York: Cambridge University Press; 2008.
9.
Friedman A: Beyond accountability for reasonableness. Bioethics 2008, 22: 101–112. 10.1111/j.1467-8519.2007.00605.xPubMedCrossRef
Metadata
Title
The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions
Authors
Sitaporn Youngkong
Noor Tromp
Dereck Chitama
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2011
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/1478-7547-9-8

Other articles of this Issue 1/2011

Cost Effectiveness and Resource Allocation 1/2011 Go to the issue

Research

Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling

Research

Impact of the introduction of new vaccines and vaccine wastage rate on the cost-effectiveness of routine EPI: lessons from a descriptive study in a Cameroonian health district

Research

Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes

Research

Cost of individual peer counselling for the promotion of exclusive breastfeeding in Uganda

Research

Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study

Review

The cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: systematic review